Praxis Precision Medicines, Inc.

NASDAQ:PRAX

Biotechnology

Healthcare
$310.90 +4.49%

+$12.13 today

Market cap
$8.69B
Beta
2.75
P/E (TTM)
-25.0
EPS (TTM)
-$11.31
52W Low $37.19High $366.52

Volume 0.63M

Average 0.45M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$326.20M

FY 2025 · Annual

Net Income

-$303.27M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue002.45M8.55M0
Cost of Revenue0154.44M86.77M152.41M140K
Gross Profit0(154.44M)(84.32M)(143.86M)(140K)
Gross Margin——-3445.8%-1682.0%—
Research & Development120.26M155.04M86.77M152.41M267.12M
Selling, General & Admin47.08M59.55M42.05M56.31M59.08M
Operating Expenses167.33M60.55M42.05M56.31M326.06M
Depreciation & Amortization182K419K432K358K140K
EBITDA(166.88M)(213.57M)(122.85M)(182.46M)(303.13M)
EBITDA Margin——-5020.2%-2133.3%—
Operating Income(167.33M)(214.99M)(126.37M)(200.17M)(326.2M)
Operating Margin——-5164.4%-2340.3%—
Interest Income00017.35M22.93M
Interest Expense00000
Other Income / Expenses271K957K3.1M17.35M22.93M
Income Before Tax(167.06M)(214.03M)(123.28M)(182.82M)(303.27M)
Pre-Tax Margin——-5037.9%-2137.5%—
Income Tax Expense00000
Net Income(167.06M)(214.03M)(123.28M)(182.82M)(303.27M)
Net Margin——-5037.9%-2137.5%—
EPS (Basic)(58.96)(69.33)(18.69)(10.21)(13.48)
EPS (Diluted)(58.96)(69.33)(18.69)(10.21)(13.48)
Weighted Avg Shares2.83M3.07M6.59M17.91M22.5M
Weighted Avg Shares (Diluted)2.83M3.07M6.59M17.91M22.5M

PRAX Earnings Waterfall · TTM

NASDAQ:PRAX · Revenue to Net Income

Key Ratios

EPS$-12.80
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-24.5
P/S Ratio0.0

Analysis

$0 of revenue converted into -$359.4M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-12.80, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
SC 13G/ASC 13G/A filingAug 14, 2026

How much revenue does PRAX generate?

Praxis Precision Medicines, Inc. (PRAX) reported $0.00 of revenue in fiscal 2025.

Is PRAX profitable?

Praxis Precision Medicines, Inc. (PRAX) reported -$303.27M of net income.